Paper Details
- Home
- Paper Details
Study of Adverse Drug Effects of Direct-Acting Antivirals for Chronic HCV Infection at Fayoum Governorate, Egypt - A Pharmacovigilance Study.
Author: Abdel WahedWafaa Y, AhmedEman I, AhmedTarek I, HassanEssam A
Original Abstract of the Article :
Different combinations of Direct Antiviral Agents (DAAs) have been used against different Hepatitis C Virus (HCV) genotypes and in different types of patients. Despite being effective and characterized by a very low rate of adverse effects in clinical trials, few data are available on adverse events...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.2174/1574886313666180716111529
データ提供：米国国立医学図書館（NLM）
Direct-Acting Antivirals: Mapping the Desert of Hepatitis C Treatment
This study, like a caravan navigating a vast and treacherous desert, explores the real-world use of direct-acting antivirals (DAAs) for chronic hepatitis C infection. Researchers, akin to skilled desert explorers, conducted a pharmacovigilance study, meticulously documenting the adverse drug effects of DAAs in a real-world setting. The study aimed to provide valuable insights into the safety and efficacy of DAAs, supplementing the information gleaned from clinical trials.
The Desert of Hepatitis C Treatment: A Landscape of Progress and Challenges
This study, like a map guiding travelers through a complex and evolving landscape, provides valuable insights into the treatment of chronic hepatitis C infection. The study's findings highlight the remarkable efficacy of DAAs, while also underscoring the importance of monitoring potential adverse effects. This study's findings serve as a reminder that the journey to effective treatment is often complex, with ongoing research and vigilance needed to ensure optimal outcomes for patients.
Navigating the Desert of Treatment: Balancing Benefits and Risks
Navigating the desert of chronic hepatitis C treatment requires a balanced approach, carefully weighing the benefits and risks of different therapies. This study, like a compass guiding travelers through a challenging terrain, provides valuable information about the safety and efficacy of DAAs. It emphasizes the importance of ongoing monitoring and research to ensure the best possible outcomes for patients with hepatitis C.
Dr.Camel's Conclusion
This study offers a glimpse into the real-world use of direct-acting antivirals (DAAs) for chronic hepatitis C infection. The study's findings, like a treasure map leading to a hidden oasis, highlight the remarkable efficacy of DAAs while also underscoring the importance of ongoing monitoring and research to ensure the safety and effectiveness of these life-changing medications.
Date :
- Date Completed 2019-01-03
- Date Revised 2021-12-04
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.